Showing 1 - 8 results of 8 for search 'Sosipatros A. Boikos', query time: 0.03s
Refine Results
-
1
Immunotherapy for Prostate Cancer Enters Its Golden Age by Sosipatros A. Boikos, Emmanuel S. Antonarakis
Published 2012-07-01
Article -
2
Immunotherapy for Prostate Cancer Enters Its Golden Age by Sosipatros A. Boikos, Emmanuel S. Antonarakis
Published 2012-01-01
Article -
3
Advances and Challenges on Management of Gastrointestinal Stromal Tumors by Lin Mei, Wei Du, Michael Idowu, Margaret von Mehren, Sosipatros A. Boikos
Published 2018-05-01
Article -
4
-
5
MYCN upregulates the transsulfuration pathway to suppress the ferroptotic vulnerability in MYCN-amplified neuroblastoma by Konstantinos V. Floros, Ayesha T. Chawla, Mia O. Johnson-Berro, Rishabh Khatri, Angeliki M. Stamatouli, Sosipatros A. Boikos, Mikhail G. Dozmorov, L. Ashley Cowart, Anthony C. Faber
Published 2022-01-01
Article -
6
Targeting transcription of MCL-1 sensitizes HER2-amplified breast cancers to HER2 inhibitors by Konstantinos V. Floros, Sheeba Jacob, Richard Kurupi, Carter K. Fairchild, Bin Hu, Madhavi Puchalapalli, Jennifer E. Koblinski, Mikhail G. Dozmorov, Sosipatros A. Boikos, Maurizio Scaltriti, Anthony C. Faber
Published 2021-02-01
Article -
7
Unmasking BCL-2 Addiction in Synovial Sarcoma by Overcoming Low NOXA by Carter K. Fairchild, Konstantinos V. Floros, Sheeba Jacob, Colin M. Coon, Madhavi Puchalapalli, Bin Hu, Hisashi Harada, Mikhail G. Dozmorov, Jennifer E. Koblinski, Steven C. Smith, Gregory Domson, Joel D. Leverson, Andrew J. Souers, Naoko Takebe, Hiromichi Ebi, Anthony C. Faber, Sosipatros A. Boikos
Published 2021-05-01
Article -
8
High-risk neuroblastoma with NF1 loss of function is targetable using SHP2 inhibition by Jinyang Cai, Sheeba Jacob, Richard Kurupi, Krista M. Dalton, Colin Coon, Patricia Greninger, Regina K. Egan, Giovanna T. Stein, Ellen Murchie, Joseph McClanaghan, Yuta Adachi, Kentaro Hirade, Mikhail Dozmorov, John Glod, Sosipatros A. Boikos, Hiromichi Ebi, Huaixiang Hao, Giordano Caponigro, Cyril H. Benes, Anthony C. Faber
Published 2022-07-01
Article